During the past decade, Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 26 clinical trials were completed, i.e. on average, 51% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 22 clinical trials were completed. i.e. 81.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH" #1 sponsor was "Boehringer Ingelheim" with 19 trials, followed by "Vertex Pharmaceuticals Incorporated" with 13 trials sponsored, "ResMed" with 8 trials sponsored, "Boston Scientific Corporation" with 3 trials sponsored and "University Hospital, Essen" with 3 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH" #1 collaborator was "CRI-The Clinical Research Institute GmbH" with 2 trials as a collaborator, "PneumRx, Inc." with 2 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator, "CAPNETZ Stiftung" with 1 trials as a collaborator and "Marta Cuyás" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH" are "Cystic Fibrosis" (19 trials), "Idiopathic Pulmonary Fibrosis" (7 trials), "Lung Diseases, Interstitial" (4 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials) and "Emphysema" (3 trials). Many other conditions were trialed in "Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH" in a lesser frequency.

Most popular intervention types in "Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH" are "Drug" (39 trials), "Device" (15 trials), "Other" (4 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "IVA" (12 trials), "ELX/TEZ/IVA" (8 trials), "Nintedanib" (6 trials) and "BI 1015550" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH" are 65 trials for "All" genders.

Currently, there are NaN active trials in "Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH". undefined are not yet recruiting, 10 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 41 completed trials in Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 12 trials that are defined as “Not Applicable".

Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH has several departments that took part in Clinical trials: "Ruhrlandklinik Lungenzentrum der UNI Essen Abt.Pneumologie-Allergologie" - 8 trials